SMO ClinPlus CO.,LTD. (SHE:301257)
China · Delayed Price · Currency is CNY 39.87
-3.13 (-7.28%)
Aug 31, 2026, 4:00 PM EDT
SMO ClinPlus CO.,LTD. Market Cap
SMO ClinPlus CO.,LTD. has a market cap or net worth of 3.15 billion as of September 1, 2026. Its market cap has decreased by -8.43% in one year.
Market Cap
3.15B
Enterprise Value
2.58B
Revenue
824.77M
Ranking
n/a
PE Ratio
57.26
Stock Price
39.87
ChartMarket Cap Chart
Since May 17, 2022, SMO ClinPlus CO.,LTD.'s market cap has decreased from 4.48B to 3.15B, a decrease of -29.66%. That is a compound annual growth rate of -7.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 3.15B | -23.39% |
| Dec 31, 2025 | 4.11B | 91.80% |
| Dec 31, 2024 | 2.14B | -44.81% |
| Dec 29, 2023 | 3.88B | 32.91% |
| Dec 30, 2022 | 2.92B | -34.76% |
| May 17, 2022 | 4.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 6.85B |
| Shanghai Runda Medical Technology | 5.93B |
| Maccura Biotechnology Co.Ltd | 5.64B |
| Cowealth Medical China | 4.93B |
| Shanghai Labway Clinical Laboratory | 4.26B |
| Guangdong Hybribio Biotech | 3.80B |
| Thalys Medical Technology Group | 3.66B |
| Medicalsystem Biotechnology | 3.60B |